S&P TSX Capped Composite...

US Dollar vs CAD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

MDGL Madrigal Pharmaceuticals Inc

297.00

-5.67 (-1.87%)

Nov 15 2024 - Closed

Delayed by 15 minutes

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Madrigal Pharmaceuticals (NASDAQ:MDGL)
Historical Stock Chart
From Oct 2024 to Nov 2024

Click Here for more Madrigal Pharmaceuticals Charts.

Madrigal Pharmaceuticals (NASDAQ:MDGL)
Historical Stock Chart
From Nov 2023 to Nov 2024

Click Here for more Madrigal Pharmaceuticals Charts.

Madrigal Pharmaceuticals Inc News

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Thursday 14 November 2024 (3 days ago) • Edgar (US Regulatory)

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Thursday 14 November 2024 (3 days ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 8 November 2024 (1 week ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Thursday 7 November 2024 (1 week ago) • Edgar (US Regulatory)

Madrigal Pharmaceuticals, Inc. Announces Participation at Three Upcoming Investor Conferences
Wednesday 6 November 2024 (2 weeks ago) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 5 November 2024 (2 weeks ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Friday 1 November 2024 (2 weeks ago) • Edgar (US Regulatory)

Form S-8 - Securities to be offered to employees in employee benefit plans
Thursday 31 October 2024 (2 weeks ago) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Thursday 31 October 2024 (2 weeks ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 31 October 2024 (2 weeks ago) • Edgar (US Regulatory)

Madrigal Pharmaceuticals Reports Third-Quarter 2024 Financial Results and Provides Corporate Updates
Thursday 31 October 2024 (2 weeks ago) • GlobeNewswire Inc.

Madrigal Pharmaceuticals to Present Multiple Rezdiffra™ (resmetirom) Abstracts in NASH/MASH at the AASLD Liver Meeting®
Wednesday 30 October 2024 (3 weeks ago) • GlobeNewswire Inc.

More Madrigal Pharmaceuticals Inc News Articles

LOBO EV Technologies

Millicom International C...

I Grandi Viaggi

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions